Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen

Life Sciences

Volumn 63, Issue 12, 1998, Pages 985-994

  Giuliani, Anna ^a,b   Porcelli, Steven A ^c,d   Tentori, Lucio ^a   Graziani, Grazia ^a   Testorelli, Carla ^e   Prete, Salvatore P ^a   Bussini, Simona ^e   Cappelletti, Daniela ^a   Brenner, Michael B ^c,d   Bonmassar, Enzo ^a,b,f   Aquino, Angelo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CNR   (Italy)

^c Lymphocyte Biology Section   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF MILAN   (Italy)

^f LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

CD1b; Double negative T cells; Rifampin; Tuberculosis

Indexed keywords

ANTIGEN; GLYCOLIPID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CHEMOPROPHYLAXIS; FLUORESCENCE ACTIVATED CELL SORTER; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN ANALYSIS; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; ANTIGENS, BACTERIAL; ANTIGENS, CD1; CELL ADHESION; CELL LINE; CELL MEMBRANE; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GLYCOLIPIDS; HUMANS; INDICATORS AND REAGENTS; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; T-LYMPHOCYTES;

EID: 0032516533     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00360-9     Document Type: Article

References (34)

1. 1. J.H. KENT, Tuberculosis 77 1391-1409 (1993).
2. 2. S.D. NIGHTINGALE, D.W. CAMERON, F.M. GORDIN, P.M. SULLAM, D.L. COHN, R.E. CHAISSON, L.J. ERON, P.D. SPARTI, B. BIHARI, D.L. KAUFMAN, J.J STERN, D.D. PEARCE, W.G. WEINBERG, A. LAMARCA and F.P. SIEGAL, N.Engl. J. Med. 329 828-833 (1993).
3. 3. E.C. BOTTGER, A. TESKE, P. KIRSCHNER, S. BOST, H.R. CHANG, V. BEER and B. HIRSCHEL, Lancet 340 76-80 (1992).
4. 4. I.M. ORME, P. ANDERSEN and W.H. BOOM, J. Infect Dis. 167 1481-1492 (1993)
5. 5. K. TSUKAGUCHI, K.N. BALAJI and W.H. BOOM, J. Immmunol. 154 1786-1796 (1995).
6. 6. B. SCHOEL, H. GULLE and S.H. KAUFMANN, Infect. Immun. 60 1717-1725 (1992).
7. 7. L.H. MARTIN, F. CALABI, F.A. LEFEBVRE, C.A.G. BILSLAND and C. ANMILSTEIN, Proc. Natl. Acad. Sci. USA 84 9189-9193 (1987).
8. 8. S.A. PORCELLI, C.T. MORITA and M.B. BRENNER, Nature 360 593-597 (1992).
9. 9. E.M. BECKMAN, S.A. PORCELLI, C.T. MORITA, S.M. BEHAR, S.T. FURLONG and M.B. BRENNER, Nature 372 691-694 (1994).
10. 10. R.S. BLUMBERG, D. GERDES, A. CHOTT, S.A. PORCELLI and S.P. BALK, Imm. Rev. 147 5-29 (1995).
11. 11. S.A. PORCELLI, Adv. Immunol. 59 1-98 (1995).
12. 12. W. KASINRERK, T. BAUMRUKER, O. MAJDIC, W. KNAPP and H. STOCKINGER, J. Immunol. 150 579-84 (1993).
13. 13. S. STENGER, R.J. MAZZACARO, K. UYEMERA, S. CHO, P.F. BARNES, J.P. ROSAR, A. SETTE, M.B. BRENNER, S.A. PORCELLI, B.R. BLOOM and R.L. MOLDIN, Science 276 1684-1687 (1997).
14. 14. L.P. NICOD, Arguments for. Schweiz. Med. Wochenschr. 123 154-158 (1993).
15. 15. R.N. BROGDEN and A. FITTON, Drugs 47 983-1009 (1994).
16. 16. M.S. IBRAHIM, Z.A. MAGED, A. HARON, R.Y. KHALIL and A.M. ATTALLAH, Chemioterapia 6 426-430 (1987).
17. 17. M.S. IBRAHTM, Z.A. MAGED, A. HARON, R.Y. KHALIL and A.M. ATTALLAH, Chemioterapia 7 369-372 (1988).
18. 18. B. VAN VLEM, R. VANHOLDER, P. DE PAEPE, D. VOGELAERS and S. RINGOIR, Infection 24 275-291 (1996).
19. 19. L. TENTORI, G. GRAZIANI, S.A. PORCELLI, M. SAGITA, M.B. BRENNER, R. MADAIO, E. BONMASSAR, A. GIULIANI and A. AQUINO, Antimicrob. Agents Chemother. 42 550-554 (1998).
20. 20. S.M. BEHAR, S.A. PORCELLI, E.M. BECKMAN and M.B. BRENNER, J. Exp. Med. 182 2007-2018 (1995).
21. 21. R. SOLANA, M.C. FERNANDEZ, C. ALONZO, C. NAVARRETE, J.A. SACHS and H. FESTENSTEIN, Dis. Markers 2 23-30 (1984).
22. 22. L. TENTORI, C. LEONETTI, G. LANZELLI and E. BONMASSAR, Int. J. Immunopharmac. 8 831-840 (1990).
23. 23. A. GIULIANI, L. TENTORI, R. PEPPONI, S.A. PORCELLI, A. AQUINO, L. ORLANDO, M. SUGITA, M.B. BRENNER, E. BONMASSAR and G. GRAZIANI, Pharm. Res. 35 135-140 (1997).
24. 24. J. ZEMMOUR, A.M. LITTLE, D. J. SCHENDEL and P. PARHAM, J. Immunol. 148 1941-1948 (1992).
25. 25. D.B. MOODY, B.B. REINHOLD, M.R. GUY, E.M. BECKMAN, D.E. FREDERIQUE, S.T. FURLONG, S. YE, V.M. REINHOLD, P.A. SIELING, R.L. MODLIN, G.S., BESRA and S.A. PORCELLI, Science 278 283-287 (1997).
26. 26. J.S. SCHOREY, M.C. CARROLL and E.J. BROWN, Science 277 1091-1093 (1997).
27. 27. J.S. TAN, D.H. CANADAY, W.H. BOOM, K.N. BALAJI, S.K. SCHWANDER and E.A. RICH, J. Immunol 159 290-297 (1997).
28. 28. R.A. HENDERSON, S.C. WATKINS and J.L. FLYNN, J. Immunol. 159 635-643 (1997).
29. 29. A. BERGERON, M. BONAY, M. KAMBOUCHNER, D. LECOSSIER, M. RIQUET, P. SOLER, A. HANCE and A. TAZI, J. Immunol. 159 3034-3043 (1997)
30. 30. J. DHILLON and D.A. MITCHISON, Br. J. Exp. Pat. 70 103-110 (1989).
31. 31. L. CHAPUIS, C. TRUFFOT-PERNOT, R.J. O'BRIEN, M.C. RAVIGLIONE and J.H. GROSSET, Am. J. Respiratory Critical Care Medicine 150 1355-1362 (1994).
32. 32. M.A. JACOBSON and W.M. ISENBERG, Am. J. Clin. Pathol. 91 236-238 (1989).
33. 33. K. ROSZKOWSKI, W. BEUTH, H.L. KO, W. ROSZKOWSKI, J. JELJASZEWICZ and G. PULVERER, Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 276 280-287 (1992).
34. 34. X. YANG and C.W. PRICE, J. Biol. Chem. 270 23930-23933 (1995).